Skip to main content
    C

    Crispr Therapeutics AG (CRSP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $40.37
    -1.87 (-4.43%)

    Market Cap: $4.10B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Crispr Therapeutics AG (CRSP) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Crispr Therapeutics AG are Cogent Biosciences (COGT), Krystal Biotech (KRYS) and Travere Therapeutics (TVTX). By market cap, Crispr Therapeutics AG ranks 8th of the 13 companies on this page; Krystal Biotech (KRYS) is the largest at $9.05B. The median P/E of the 3 companies with a P/E is 129.3x.

    Peer Comparison

    CRSP's ROIC of -20.3% is above the peer median of -26.4%, and its revenue growth of 1325.0% is above the median of 11.2%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Crispr Therapeutics AG (CRSP)$4.10BN/A155.2x0.0%-20.3%1325.0%0.00%
    Cogent Biosciences Inc (COGT)$4.97BN/AN/A0.0%-43.4%-100.0%0.00%
    Krystal Biotech Inc (KRYS)$9.05B40.4x18.8x47.9%N/A30.2%0.00%
    Travere Therapeutics Inc (TVTX)$4.86BN/A7.2x-18.7%-23.1%36.2%0.00%
    PTC Therapeutics Inc (PTCT)$5.30BN/A5.2x-9.2%18.1%69.6%0.00%
    Beam Therapeutics Inc (BEAM)$2.36BN/A15.0x-73.9%-29.7%-96.8%0.00%
    Viridian Therapeutics Inc (VRDN)$3.51BN/A128.5x0.0%-41.8%-63.5%0.00%
    Arcutis Biotherapeutics Inc (ARQT)$3.57B129.3x7.0x5.9%7.8%45.1%0.00%
    Erasca Inc (ERAS)$5.50BN/AN/A0.0%N/A0.0%0.00%
    Telix Pharmaceuticals Limited (TLX)$3.14BN/A5.3x3.8%-0.7%22.3%0.00%
    Scholar Rock Holding Corp (SRRK)$5.27BN/AN/A0.0%-89.0%-100.0%0.00%
    Edgewise Therapeutics Inc (EWTX)$5.03BN/AN/A0.0%N/A0.0%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Peer median$4.92B129.3x7.1x0.0%-26.4%11.2%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Crispr Therapeutics AG, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Cogent Biosciences Inc (COGT)
    Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases.
    COGT competitors
    Krystal Biotech Inc (KRYS)
    Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United...
    KRYS competitors
    Travere Therapeutics Inc (TVTX)
    Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification...
    TVTX competitors
    PTC Therapeutics Inc (PTCT)
    PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders.
    PTCT competitors
    Beam Therapeutics Inc (BEAM)
    Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States.
    BEAM competitors
    Viridian Therapeutics Inc (VRDN)
    Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses.
    VRDN competitors
    Arcutis Biotherapeutics Inc (ARQT)
    Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
    ARQT competitors
    Erasca Inc (ERAS)
    Erasca Inc. is a pioneering biopharmaceutical firm specializing in the development of targeted therapies for genetically defined cancers...
    ERAS competitors
    Telix Pharmaceuticals Limited (TLX)
    Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic...
    Scholar Rock Holding Corp (SRRK)
    Scholar Rock Holding Corporation, a clinical-phase biopharmaceutical company, is focused on the discovery and development of drugs for the treatment of serious...
    SRRK competitors
    Edgewise Therapeutics Inc (EWTX)
    Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases.
    EWTX competitors
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors

    Frequently Asked Questions About CRSP

    Who are Crispr Therapeutics AG's main competitors?

    The companies most similar to Crispr Therapeutics AG include Cogent Biosciences (COGT), Krystal Biotech (KRYS), Travere Therapeutics (TVTX), PTC Therapeutics (PTCT) and Beam Therapeutics (BEAM), listed from the closest match.

    Who is Crispr Therapeutics AG's biggest competitor?

    Krystal Biotech (KRYS) is the largest of the similar companies at $9.05B; Cogent Biosciences (COGT) is the closest match by business profile, size, sector and industry.

    How does CRSP stock compare with its competitors?

    CRSP's P/S is 155.2x against a peer median of 7.1x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Crispr Therapeutics AG's competitors pays a higher dividend?

    Crispr Therapeutics AG pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Crispr Therapeutics AG bigger than its competitors?

    No. Crispr Therapeutics AG is 8th by market cap among the 13 companies on this page; the largest is Krystal Biotech (KRYS) at $9.05B.